AAG
VRTX icon

Accordant Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Accordant Advisory Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$3.39K – 184
2025
Q1 		$3.39K Buy
+7
New +$3.39K ﹤0.01% 129